M&A Deal Summary |
|
|---|---|
| Date | 2013-08-22 |
| Target | Synagro Technologies |
| Sector | Environmental |
| Buyer(s) | EQT |
| Deal Type | Special Situations/Distressed |
| Deal Value | 465M USD |
| Advisor(s) | Skadden, Arps, Slate, Meagher & Flom (Legal) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1994 |
| PE ASSETS | 242.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
EQT is a global private equity group that purses a variety of investment strategies around the world. EQT is divided into several investment disciplines, including private capital, real assets, credit, and venture. The Firm's private capital group targets large, market-leading enterprises (investment size of €125 to €1.5 billion) across Europe and the US, as well as mid-market, growth companies (investment size of €40 to €125 million) across the US, Europe, China, and Southeast Asia. The Firm's real assets group seeks to identify control or co-control equity investments (investment size of €500 to €1 billion) in medium-sized infrastructure companies that provide an essential service to society, are recession resilient, and have secure cash flows. EQT's credit group provides flexible, long-term debt capital solutions to medium-sized European businesses, across a wide range of sectors. EQT was established in 1994 and is headquartered in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 110 of 318 |
| Sector: Environmental M&A | 2 of 9 |
| Type: Special Situations/Distressed M&A Deals | 1 of 1 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 8 of 60 |
| Year: 2013 M&A | 5 of 8 |
| Size (of disclosed) | 33 of 44 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-08-14 |
Swiss Smile
Zurich, Switzerland Swiss Smile is a provider of dental care and services and differentiates itself through a strong brand, high medical standards, convenient opening hours, a modern infrastructure, and an outstanding patient experience. Swiss Smile was founded in 2002 and is based in Zurich, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-06 |
Gambro AB
Stockholm, Sweden Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products, therapies and services for In-center Care and Self Care hemodialysis, Peritoneal Dialysis, Renal Intensive Care and Hepatic Care. Gambro was founded in 1964 and has more than 8,000 employees, production facilities in 11 countries, sales subsidiaries in more than 40 and sales in more than 100 countries. |
Sell | $3.9B |
